In a new study, the results of which were recently published in the "Science" magazine, a joint research team from several American and international universities, most notably the Massachusetts Institute of Technology and Harvard University, was able to design a new vaccine that showed primary efficacy in preventing HIV infection that causes AIDS, in addition to To several other deadly viral species.
The new vaccine focuses on stimulating the immune system to produce ready antibodies that can attack the target virus, and these antibodies can also attack other rapidly mutating viral chains by attaching to important and difficult-to-reach areas in the surfaces of these viruses, which are almost common areas and do not differ much from one strain to another. .
According to the researchers, the new vaccine, if successful, could save millions of lives and save millions of dollars spent in treating AIDS cases, and ultimately eliminating AIDS as a threat to public health.
It is worth noting that, until last year, the number of people living with HIV / AIDS around the world reached about 37 million, of whom about one million died in the same year.
